Loading organizations...
Loading organizations...
Biotechnology company developing targeted cancer chemo-immunotherapies.
MaveriX Oncology has raised $6.5M across 1 funding round.
MaveriX Oncology has raised $6.5M in total across 1 funding round.
MaveriX Oncology has raised $6.5M in total across 1 funding round.
MaveriX Oncology's investors include PPF Group.
MaveriX Oncology has raised $6.5M across 1 funding round. Most recently, it raised $6.5M Series A in October 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 14, 2019 | $6.5M Series A | PPF Group |